The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
Open accessAbstract
Background—: Safe, effective therapy is needed for pediatric pulmonary arterial hypertension. Methods and Results—: Children (n=235; weight ≥8 kg) were randomized to low-, medium-, or high-dose sildenafil or placebo orally 3 times daily for 16 weeks in the Sildenafil in Treatment-Naive Children, Aged 1–17 Years, With Pulmonary Arterial Hypertension (STARTS-1) study. The primary comparison was percent change from baseline in peak oxygen consumption (PV̇ o 2 ) for the 3 sildenafil doses combined versus placebo. Exercise testing was performed in 115 children able to exercise reliably; the study was powered for this population. Secondary end points (assessed in all patients) included hemodynamics and functional class. The estimated mean±SE percent change in PV̇ o 2 for the 3 doses combined versus placebo was 7.7±4.0% (95% confidence interval, −0.2% to 15.6%; P =0.056). PV̇ o 2 , functional class, and hemodynamics improved with medium and high doses versus placebo; low-dose sildenafil was ineffective. Most adverse events were mild to moderate in severity. STARTS-1 completers could enter the STARTS-2 extension study; patients who received sildenafil in STARTS-1 continued the same dose, whereas placebo-treated patients were randomized to low-, medium-, or high-dose sildenafil. In STARTS-2 (ongoing), increased mortality was observed with higher doses. Conclusions—: Sixteen-week sildenafil monotherapy is well tolerated in pediatric pulmonary arterial hypertension. Percent change in PV̇ o 2 for the 3 sildenafil doses combined was only marginally significant; however, PV̇ o 2 , functional class, and hemodynamic improvements with medium and high doses suggest efficacy with these doses. Combined with STARTS-2 data, the overall profile favors the medium dose. Further investigation is warranted to determine optimal dosing based on age and weight. Clinical Trial Registration—: http://www.clinicaltrials.gov . Unique identifier: NCT00159913.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A General Model for the Origin of Allometric Scaling Laws in Biology
West, G. B., Brown, J. H., & Enquist, B. J. (1997) · Science · doi:10.1126/science.276.5309.122 · Cited by 5,016
Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., Garrigue, S., Kappenberger, L., Haywood, G. A., Santini, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441202 · Cited by 2,751
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationCellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Benza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Self-citationMIYAMOTO, S., NAGAYA, N., SATOH, T., KYOTANI, S., SAKAMAKI, F., FUJITA, M., NAKANISHI, N., & MIYATAKE, K. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9906015 · Cited by 1,154
Diagnosis and Assessment of Pulmonary Arterial Hypertension
Badesch, D. B., Champion, H. C., Gomez Sanchez, M. A., Hoeper, M. M., Loyd, J. E., Manes, A., McGoon, M., Naeije, R., Olschewski, H., Oudiz, R. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.011 · Cited by 1,138
Galiè, N., Humbert, M., Vachiéry, J.-L., Vizza, C., Kneussl, M., Manes, A., Sitbon, O., Torbicki, A., Delcroix, M., Naeije, R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01786-2 · Cited by 648
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 629
Genetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R., Grünig, E., Aldred, M., Geraci, M., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 616
BALLARD, S. A., GINGELL, C. J., TANG, K., TURNER, L. A., PRICE, M. E., & NAYLOR, A. M. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63299-3 · Cited by 591
Prognosis of Pulmonary Arterial Hypertension*
McLaughlin, V. V., Presberg, K. W., Doyle, R. L., Abman, S. H., McCrory, D. C., Fortin, T., & Ahearn, G. (2004) · Chest · doi:10.1378/chest.126.1_suppl.78s · Cited by 511
Ambrisentan Therapy for Pulmonary Arterial Hypertension
Galié, N., Badesch, D., Oudiz, R., Simonneau, G., McGoon, M. D., Keogh, A. M., Frost, A. E., Zwicke, D., Naeije, R., Shapiro, S., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.050 · Cited by 494
Clinical efficacy of sildenafil in primary pulmonary hypertension
Sastry, B. K. S., Narasimhan, C., Reddy, N. K., & Raju, B. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.056 · Cited by 488
Self-citationA Size Standard for Pharmacokinetics
Holford, N. H. G. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00001 · Cited by 482
Vasodilator Therapy for Primary Pulmonary Hypertension in Children
Barst, R. J., Maislin, G., & Fishman, A. P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1197 · Cited by 427
Self-citationAuricchio, A., Stellbrink, C., Butter, C., Sack, S., Vogt, J., Misier, A. R., Böcker, D., Block, M., Kirkels, J. H., Kramer, A., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.04.003 · Cited by 409
Genetics and Genomics of Pulmonary Arterial Hypertension
Machado, R. D., Eickelberg, O., Elliott, C. G., Geraci, M. W., Hanaoka, M., Loyd, J. E., Newman, J. H., Phillips, J. A., Soubrier, F., Trembath, R. C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.015 · Cited by 372
Sildenafil in Primary Pulmonary Hypertension
Prasad, S., Wilkinson, J., & Gatzoulis, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431814 · Cited by 337
The 6-minute walk test: normal values for children of 4-11 years of age
Lammers, A. E., Hislop, A. A., Flynn, Y., & Haworth, S. G. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.123653 · Cited by 315
Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension
Rosenzweig, E. B., Ivy, D. D., Widlitz, A., Doran, A., Claussen, L. R., Yung, D., Abman, S. H., Morganti, A., Nguyen, N., & Barst, R. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.066 · Cited by 264
Self-citationChildhood idiopathic pulmonary arterial hypertension: a national cohort study
Moledina, S., Hislop, A. A., Foster, H., Schulze-Neick, I., & Haworth, S. G. (2010) · Heart · doi:10.1136/hrt.2009.182378 · Cited by 239
Scaling for size: some implications for paediatric anaesthesia dosing
Anderson, B. J., & Meakin, G. H. (2002) · Pediatric Anesthesia · doi:10.1046/j.1460-9592.2002.00616.x · Cited by 195
Simple procedures for blinded sample size adjustment that do not affect the type I error rate
Kieser, M., & Friede, T. (2003) · Statistics in Medicine · doi:10.1002/sim.1585 · Cited by 141
Beghetti, M., Haworth, S. G., Bonnet, D., Barst, R. J., Acar, P., Fraisse, A., Ivy, D. D., Jaïs, X., Schulze‐Neick, I., Galiè, N., et al. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03532.x · Cited by 116
Self-citationIvy, D. D., Rosenzweig, E. B., Lemarié, J., Brand, M., Rosenberg, D., & Barst, R. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.064 · Cited by 115
Self-citationvan Loon, R. L. E., Hoendermis, E. S., Duffels, M. G. J., Noordegraaf, A. V., Mulder, B. J. M., Hillege, H. L., & Berger, R. M. F. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.003 · Cited by 112
Genetics of pulmonary hypertension: from bench to bedside
Humbert, M. J. C., & Trembath, R. C. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.02702002 · Cited by 64
Safety of Maximal Cardiopulmonary Exercise Testing in Pediatric Patients With Pulmonary Hypertension
Smith, G., Reyes, J. T., Russell, J. L., & Humpl, T. (2008) · CHEST Journal · doi:10.1378/chest.08-1658 · Cited by 36
Barst, R. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.1.95 · Cited by 35
Self-citation
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Abman, S. H., Hansmann, G., Archer, S. L., Ivy, D. D., Adatia, I., Chung, W. K., Hanna, B. D., Rosenzweig, E. B., Raj, J. U., Cornfield, D., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000329 · Cited by 1,164
Self-citation
Metadata
- Authors
- Barst, R. J., Ivy, D. D., Gaitan, G., Szatmari, A., Rudzinski, A., Garcia, A. E., Sastry, B. K. S., Pulido, T., Layton, G. R., Serdarevic-Pehar, M., & Wessel, D. L.
- Venue
- Circulation
- Published
- 2012-01-17
- Volume
- 125
- Issue
- 2
- Pages
- 324-334
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2109335746
- Cited by
- 372
- References
- 30
- FWCI
- 28.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.